New estimates of pharmaceutical research and development spending by US-based firms from 1984 to 2003

Managerial and Decision Economics

Volumn 28, Issue 4-5, 2007, Pages 481-483

  Golec, Joseph ^a   Vernon, John A ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34548314497     PISSN: 01436570     EISSN: 10991468     Source Type: Journal    
DOI: 10.1002/mde.1362     Document Type: Article

References (6)

1. Giaccotto C, Santerre R, Vernon J. 2005, Drug prices and research and development investment behavior in the pharmaceutical industry, Journal of Law and Economics 48: 195-214.
2. Hall BH, Long WF. 1999. Differences in reporting R&D data on the NSF/Census RD-1 form and the SEC 10-K form: a micro-data investigation. Report to the National Science Foundation.
3. National Science Foundation. Survey of Industrial Research and Development, www.nsf.gov/statistics/showpub.cfm?TopID = 5&SubID = 36.
4. Pharmaceutical Research and Manufacturers of America. 2005. Pharmaceutical Industry Profile 2005. PhRMA: Washington, DC.
5. Reed LJ, Campbell PM. 1988. Health care innovation: a progress report. Health Affairs 7: 174-186.
6. Scherer FM. 2001. The link between gross profitability and pharmaceutical R&D spending. Health Affairs 20: 216-220.